title: Late effects surveillance system after childhood cancer in Germany, austria and parts of Switzerland--update 2009.
authors.affiliation: Paediatric Oncology, Hospital for Children and Adolescents of the University of Erlangen-Nuremberg, Erlangen, Germany.
authors.forename: Joanna
authors.initials: J
authors.lastname: Peeters
authors.forename: Johannes
authors.initials: J
authors.lastname: Meitert
authors.forename: Marios
authors.initials: M
authors.lastname: Paulides
authors.forename: Jörn D
authors.initials: JD
authors.lastname: Beck
authors.forename: Thorsten
authors.initials: T
authors.lastname: Langer
mesh_terms: D000293:Adolescent; D000359:Aftercare; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001317:Austria; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D009202:Cardiomyopathies / Q000139:chemically induced; D002648:Child; D003131:Combined Modality Therapy; D003430:Cross-Sectional Studies; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use; D005858:Germany; D006321:Heart / Q000528:radiation effects; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects / Q000627:therapeutic use; D007668:Kidney / Q000528:radiation effects; D007673:Kidney Cortex Necrosis / Q000139:chemically induced; D015337:Multicenter Studies as Topic; D012516:Osteosarcoma / Q000188:drug therapy* / Q000532:radiotherapy*; D011159:Population Surveillance / Q000379:methods*; D011446:Prospective Studies; D011788:Quality of Life; D011832:Radiation Injuries / Q000453:epidemiology / Q000209:etiology*; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D012042:Registries; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D012509:Sarcoma / Q000188:drug therapy* / Q000532:radiotherapy*; D012512:Sarcoma, Ewing / Q000188:drug therapy* / Q000532:radiotherapy*; D017741:Survivors / Q000706:statistics & numerical data*; D013557:Switzerland
chemical_list: D004317:Doxorubicin; D007069:Ifosfamide
references.citation: Klin Padiatr. 2009 May-Jun;221(3):156-61
references.pmid: 19437363
references.citation: Strahlenther Onkol. 2008 Feb;184(2):67-72
references.pmid: 18259697
references.citation: Klin Padiatr. 2007 May-Jun;219(3):173-8
references.pmid: 17525912
references.citation: Strahlenther Onkol. 2008 Mar;184(3):137-44
references.pmid: 18330509
references.citation: Strahlenther Onkol. 2008 Jun;184(6):289-95
references.pmid: 18535803
references.citation: Circulation. 2005 Dec 13;112(24):3754-62
references.pmid: 16330681
references.citation: Klin Padiatr. 2008 Nov-Dec;220(6):371-7
references.pmid: 18949673
references.citation: Klin Padiatr. 2008 May-Jun;220(3):159-65
references.pmid: 18478488
references.citation: Klin Padiatr. 2007 May-Jun;219(3):152-7
references.pmid: 17525909
references.citation: Strahlenther Onkol. 2007 Dec;183 Spec No 2:7-8
references.pmid: 18166996